Ligand binding assays in the 21st Century laboratory: automation.
作者信息
Ahene Ago B, Morrow Chris, Rusnak David, Spitz Susan, Usansky Joel, Pils Holger, Civoli Francesca, Pandya Kinnari, Sue Brian, Leach Daniel, Derent John
机构信息
XOMA Corporation, Berkeley, California 94710, USA.
出版信息
AAPS J. 2012 Mar;14(1):142-53. doi: 10.1208/s12248-012-9323-z.
Abstract
摘要
相似文献
1
Ligand binding assays in the 21st Century laboratory: automation.
AAPS J. 2012 Mar;14(1):142-53. doi: 10.1208/s12248-012-9323-z.
2
Ligand binding assays in the 21st Century laboratory: platforms.
AAPS J. 2012 Mar;14(1):113-8. doi: 10.1208/s12248-012-9321-1.
3
Ligand-binding assays in the 21st Century laboratory: recommendations for an automated data interchange process.
AAPS J. 2012 Mar;14(1):105-12. doi: 10.1208/s12248-011-9319-0. Epub 2012 Jan 14.
4
Big pharma slims down to bolster productivity.
Nat Rev Drug Discov. 2007 Mar;6(3):173-4. doi: 10.1038/nrd2284.
5
Efficient and effective compound management to support lead optimization.
J Biomol Screen. 2009 Jun;14(5):523-30. doi: 10.1177/1087057109335747. Epub 2009 May 29.
6
How artificial intelligence is changing drug discovery.
Nature. 2018 May;557(7707):S55-S57. doi: 10.1038/d41586-018-05267-x.
7
Masters of efficiency.
Nature. 2006 Sep 7;443(7107):116-7. doi: 10.1038/nj7107-116a.
8
Size up this critical medical laboratory automation component.
MLO Med Lab Obs. 2005 Jul;37(7):22, 24, 26, 28.
9
Lab automation and robotics: Automation on the move.
Nature. 2003 Feb 6;421(6923):661, 663, 665-6. doi: 10.1038/421661a.
10
Improving quality of patient care in an emergency department: a laboratory perspective.
Am J Clin Pathol. 2008 Oct;130(4):573-7. doi: 10.1309/DGXYTH0VNTTQRQHD.
引用本文的文献
1
Ligand binding assays in the 21st century laboratory-a call for change.
AAPS J. 2012 Sep;14(3):377-9. doi: 10.1208/s12248-012-9351-8. Epub 2012 Apr 3.
本文引用的文献
1
Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification.
J Pharm Biomed Anal. 2010 Nov 2;53(3):623-30. doi: 10.1016/j.jpba.2010.04.025. Epub 2010 Apr 28.
2
Application of multi-factorial design of experiments to successfully optimize immunoassays for robust measurements of therapeutic proteins.
J Pharm Biomed Anal. 2009 Feb 20;49(2):311-8. doi: 10.1016/j.jpba.2008.11.039. Epub 2008 Dec 6.
3
Optimizing ELISAs for precision and robustness using laboratory automation and statistical design of experiments.
J Immunol Methods. 2008 Aug 20;337(1):35-41. doi: 10.1016/j.jim.2008.05.012. Epub 2008 Jun 12.
4
Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.
Pharm Res. 2003 Nov;20(11):1885-900. doi: 10.1023/b:pham.0000003390.51761.3d.
5
An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors.
Drug Discov Today. 2003 Sep 1;8(17):785-92. doi: 10.1016/s1359-6446(03)02809-5.
6
Application of experimental design techniques to optimize a competitive ELISA.
J Immunol Methods. 1996 Apr 19;190(2):151-61. doi: 10.1016/0022-1759(95)00262-6.
Zotero 插件